This inventor holds 2 USPTO granted patents and 7 published patent applications and 2 EPO patents. Top assignee: Isis Innovation Limited. Active years: 2013-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2018
Title: Mark Lathrop: Innovator in Diagnostic Methods
Introduction
Mark Lathrop is a notable inventor based in Paris, France. He has made significant contributions to the field of diagnostic methods, particularly in understanding statin-induced myopathy. With a total of 2 patents, Lathrop's work has the potential to impact medical diagnostics and patient care.
Latest Patents
Lathrop's latest patents focus on innovative diagnostic methods. One of his inventions relates to determining the susceptibility of an individual to statin-induced myopathy. This method involves detecting the presence or absence of one or more polymorphisms in the SLCO1B1 gene from a biological sample. The presence of these polymorphisms indicates that the individual has altered susceptibility to statin-induced myopathy.
Career Highlights
Throughout his career, Mark Lathrop has worked with prominent organizations such as Isis Innovation Limited and Oxford University Innovation Limited. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of diagnostics.
Collaborations
Lathrop has collaborated with notable coworkers, including Emma Link and Sarah Parish. Their combined expertise has contributed to the advancement of diagnostic methods in the medical field.
Conclusion
Mark Lathrop's contributions to diagnostic methods highlight his role as an innovator in the medical field. His work on statin-induced myopathy has the potential to improve patient outcomes and advance medical diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile